Skip navigation.
Home

archives

Older women's estrogen pills increase risks of blood clots

... ...

Estrogen-only pill, blood clots linked

... thrombosis, which involves clots that form in large veins, usually in the leg. These clots can travel to the lungs, sometimes with deadly consequences.

Dr. Nanette Santoro, a reproductive endocr ...

Appeals Court Rules in Sanofi-Aventis' Favor in the US Lovenox(R) ...

... Sanofi-aventis :: Appeals Court Rules in Sanofi-Aventis' Favor in the U.S. Lovenox(R) (enoxaparin sodium injection) Patent Infringement Case ...

Postmenopausal hormone therapy increase risk of blood clots in ...

... thrombosis, the formation of blood clots in the veins, among postmenopausal women who have had their uterus removed, according to a study in the April 10 issue of Archives of Internal Medicine, one of ...

Studies link health problems to estrogen therapy

... thrombosis and pulmonary embolism.

In that study, 197 women out of over 10,000 developed venous thromboembolism. 111 had taken estrogen and 86 had taken the placebo. Researchers also note the VT ...

Estrogen pills raise risk of blood clots: study

... thrombosis, which involves clots that form in large veins, usually in the leg. These clots can travel to the lungs, sometimes with deadly consequences.

Dr. Nanette Santoro, a reproductive endocr ...

Estrogen-only pills raise blood-clot risk

... thrombosis, which involves clots that form in large veins, usually in the leg. These clots can travel to the lungs, sometimes with deadly consequences.

Dr. Nanette Santoro, a reproductive endocr ...

Oestrogen ups clotting risk

... ...

Estrogen therapy may increase the risk of venous thrombosis

... thrombosis Home Page ...

Study Finds Hormone Therapy Risk for Black Women

... thrombosis, or DVT. The clots can be lethal when they travel through the bloodstream and lodge in a lung.

"This is the first large clinical trial of estrogen, looking at DVT," said Dr. J. David ...

US Federal Appeals Court: Teva can’t sell Lovenox

... Globes [online] - US Federal Appeals Court: Teva can't sell Lovenox ...

Hormone therapy: 0 for 2

... thrombosis, or DVT. The clots can be lethal when they travel through the bloodstream and lodge in a lung.

"This is the first large clinical trial of estrogen, looking at DVT," said Dr. J. David ...

New study ties estrogen pills to blood clots

... thrombosis, which involves clots that form in large veins, usually in the leg. These clots can travel to the lungs, sometimes with deadly consequences.

Dr. Nanette Santoro, a reproductive endocr ...

Another blow for hormone drugs

... Another blow for hormone drugs - The Boston Globe '); //--> ...

Estrogen-only pills increase women's risk for blood clots

... thrombosis, which involves clots that form in large veins, usually in the leg. These clots can travel to the lungs, sometimes with deadly consequences.

Dr. Nanette Santoro, a reproductive endocr ...

Estrogen-only pills raise risk of blood clots in older women

... thrombosis, which involves clots that form in large veins, usually in the leg. These clots can travel to the lungs, sometimes with deadly consequences.

Dr. Nanette Santoro, a reproductive endocr ...

Paris shares down midday as oil price surge spooks investors

... thrombosis treatment Lovenox.

The tribunal had ruled in June last year in favour of Amphastar Pharmaceuticals and Teva in their challenge of the intellectual property rights over Lovenox.

...

Estrogen-only pills' risks grow

... thrombosis, which involves clots that form in large veins, usually in the leg. These clots can travel to the lungs, sometimes with deadly consequences.

Dr. Nanette Santoro, a reproductive endocr ...

Hormone Therapy: 0 for 2: Studies Find High Risk of Breast Cancer ...

... thrombosis, or DVT. The clots can be lethal when they travel through the bloodstream and lodge in a lung.

"This is the first large clinical trial of estrogen, looking at DVT," said Dr. J. David ...

Appeals Court Rules in Sanofi-Aventis' Favor in the US Lovenox ...

... thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi-aventis is listed in Paris and in New York .

This press release contains forward-looking ...